CasNo.366789-02-8,99% Purity Rivaroxaban CAS: 366789-02-8 Pharmaceutical Raw Material,(366789-02-8) Suppliers

10 Gram	FOB Price: USD 100.0000

Min.Order :10 Gram
Purity: 99.00%
Payment Terms : T/T,,MoneyGram,Other

Keywords

Rivaroxaban factory price Rivaroxaban real supplier 366789-02-8

Quick Details

Appearance:powder
Application:in research
PackAge:Aluminum foil bag/as requirements
ProductionCapacity:800|Kilogram|Month
Storage:store in a cool dry place and keep away from strong
Transportation:by air or by sea

Superiority:

Inner Mongolia Yong Ming Technology Co.,Ltd--- a worthy to be depended and trusted Pharmaceutical Intermediates company. We make sure the good quality product and reasonable price. We have the good after-sales service, to solve any kinds of problems, the goal is making every customer satisfy with our company and gain the best reputation.

There are variety of products for your choose. Please contact with us at any time.

Our promise:

1. Good quality product and reasonable price~ make customers happy and save customers’ money

2. Delivery product on time~ save customers’ time

3. Professional packing~let the customers receive it successfully

4. Many payment instruments~convenient to pay

5. Service customers forever~ to establish long-term cooperation relationship

Welcome to your inquire and suggestions, everyone here do the best for you!

Details:

Product Description

1. the products information
keywords:Streptokinase,Rivaroxaban,CAS:366789-02-8,China GMP Standard Active Pharmaceutical Ingredient Fondaparinux Sodium,Find details about China Rivaroxaban,366789-02-8 from GMP Standard.

Rivaroxaban

Category:	Pharmaceuticals and Biochemicals/Blood system agents
CAS NO:	366789-02-8
Molecular Formula:	C19H18ClN3O5S
Molecular Weight:	435.8813
InChI:	InChI=1/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1
Synonyms:	5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;Rivaroxaban intermediates;5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide;rivaroxban;

Rivaroxaban Usage:
Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valve disease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke).
Rivaroxaban can also be used to prevent the formation of blood clots in the veins in adults who have had an operation to replace a hip or knee and following an acute deep venous thrombosis in adults.

Rivaroxaban Applications:
Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke)
Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults. It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.
Rivaroxaban is not indicated for prosthetic heart valves or for mitral stenosis.
Rivaroxaban is not indicated as an add-on treatment for dual antiplatelet therapy in the secondary prevention of coronary incidents (double and triple therapy). In Europe, however, a 2.5-mg twice-daily dose was approved by the European Commission after a recommendation by the European Medicines Agency (EMA) for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.

for more informaiton: candy@nmg-ym.com

skype: live:candy_3920